Cue Biopharma Inc (NASDAQ: CUE) Is Getting Increasingly Hard To Ignore
Currently, there are 60.21M common shares owned by the public and among those 59.65M shares have been available to trade. The company’s stock has a 5-day price change of 38.84% and 126.26% over the past three months. CUE shares are trading -36.36% year to date (YTD), with the 12-month market performance down to -10.16% lower. […]
